70 related articles for article (PubMed ID: 3133131)
21. Biomonitoring Human Albumin Adducts: The Past, the Present, and the Future.
Sabbioni G; Turesky RJ
Chem Res Toxicol; 2017 Jan; 30(1):332-366. PubMed ID: 27989119
[TBL] [Abstract][Full Text] [Related]
22. Chronic aflatoxin exposure in children living in Bhaktapur, Nepal: Extension of the MAL-ED study.
Mitchell NJ; Riley RT; Egner PA; Groopman JD; Wu F
J Expo Sci Environ Epidemiol; 2017 Jan; 27(1):106-111. PubMed ID: 26732375
[TBL] [Abstract][Full Text] [Related]
23. Mass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and Hepatocytes.
Wang Y; Peng L; Bellamri M; Langouët S; Turesky RJ
Chem Res Toxicol; 2015 May; 28(5):1045-59. PubMed ID: 25815793
[TBL] [Abstract][Full Text] [Related]
24. Determination of urinary biomarkers for assessment of short-term human exposure to aflatoxins in São Paulo, Brazil.
Jager AV; Tonin FG; Souto PC; Privatti RT; Oliveira CA
Toxins (Basel); 2014 Jul; 6(7):1996-2007. PubMed ID: 25007123
[TBL] [Abstract][Full Text] [Related]
25. The molecular epidemiology of chronic aflatoxin driven impaired child growth.
Turner PC
Scientifica (Cairo); 2013; 2013():152879. PubMed ID: 24455429
[TBL] [Abstract][Full Text] [Related]
26. Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisin.
Mitchell NJ; Xue KS; Lin S; Marroquin-Cardona A; Brown KA; Elmore SE; Tang L; Romoser A; Gelderblom WC; Wang JS; Phillips TD
J Appl Toxicol; 2014 Jul; 34(7):795-804. PubMed ID: 24193864
[TBL] [Abstract][Full Text] [Related]
27. Global DNA methylation in a population with aflatoxin B1 exposure.
Wu HC; Wang Q; Yang HI; Tsai WY; Chen CJ; Santella RM
Epigenetics; 2013 Sep; 8(9):962-9. PubMed ID: 23867725
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma and food contamination: aflatoxins and ochratoxin A as a great prompter.
Felizardo RJ; Câmara NO
World J Gastroenterol; 2013 Jun; 19(24):3723-5. PubMed ID: 23840111
[TBL] [Abstract][Full Text] [Related]
29. Human aflatoxin exposure in Kenya, 2007: a cross-sectional study.
Yard EE; Daniel JH; Lewis LS; Rybak ME; Paliakov EM; Kim AA; Montgomery JM; Bunnell R; Abudo MU; Akhwale W; Breiman RF; Sharif SK
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2013; 30(7):1322-31. PubMed ID: 23767939
[TBL] [Abstract][Full Text] [Related]
30. Exposure measurement of aflatoxins and aflatoxin metabolites in human body fluids. A short review.
Leong YH; Latiff AA; Ahmad NI; Rosma A
Mycotoxin Res; 2012 May; 28(2):79-87. PubMed ID: 23606045
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.
Turesky RJ; Le Marchand L
Chem Res Toxicol; 2011 Aug; 24(8):1169-214. PubMed ID: 21688801
[TBL] [Abstract][Full Text] [Related]
32. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
Wogan GN; Kensler TW; Groopman JD
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
[TBL] [Abstract][Full Text] [Related]
33. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology.
Kensler TW; Roebuck BD; Wogan GN; Groopman JD
Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S28-48. PubMed ID: 20881231
[TBL] [Abstract][Full Text] [Related]
34. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.
Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):846-53. PubMed ID: 19273485
[TBL] [Abstract][Full Text] [Related]
35. Long-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescence.
Scholl PF; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1436-9. PubMed ID: 18559559
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.
Liu ZM; Li LQ; Peng MH; Liu TW; Qin Z; Guo Y; Xiao KY; Ye XP; Mo XS; Qin X; Li S; Yan LN; Shen HM; Wang L; Wang Q; Wang KB; Liang RX; Wei ZL; Ong CN; Santella RM; Peng T
Cancer Lett; 2008 May; 263(2):212-22. PubMed ID: 18280645
[TBL] [Abstract][Full Text] [Related]
37. Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations.
Tao P; Zhi-Ming L; Tang-Wei L; Le-Qun L; Min-Hao P; Xue Q; Lu-Nam Y; Ren-Xiang L; Zong-Liang W; Lian-Wen W; Qiao W; Han-Ming S; Choon-Nam O; Santella RM
Dig Dis Sci; 2005 Mar; 50(3):525-32. PubMed ID: 15810636
[TBL] [Abstract][Full Text] [Related]
38. Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan.
Sun CA; Wu DM; Wang LY; Chen CJ; You SL; Santella RM
Br J Cancer; 2002 Oct; 87(9):966-70. PubMed ID: 12434285
[TBL] [Abstract][Full Text] [Related]
39. Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.
Ahsan H; Wang LY; Chen CJ; Tsai WY; Santella RM
Environ Health Perspect; 2001 Aug; 109(8):833-7. PubMed ID: 11564620
[TBL] [Abstract][Full Text] [Related]
40. Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.
Wang JS; Abubaker S; He X; Sun G; Strickland PT; Groopman JD
Appl Environ Microbiol; 2001 Jun; 67(6):2712-7. PubMed ID: 11375185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
